Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 29.6B | 23.7B | 30.6B | 28.3B |
Cost of revenue | 3.7B | 2.6B | 5.9B | 2.2B |
Gross profit | 25.9B | 21.0B | 24.7B | 26.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.7B | 1.7B | 1.7B | 1.6B |
Operating income | 16.1B | 12.9B | 16.5B | 18.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 17.4B | 9.4B | 13.7B | 14.4B |
Other income expense | — | — | — | — |
Pretax income | 4.1B | 2.9B | 4.4B | 6.3B |
Tax provision | 1.2B | -1.1B | 260M | 1.8B |
Net income | 3.8B | 4.7B | 5.2B | 6.3B |
Basic EPS | — | 2.9 | 1.6 | 2.6 |
Diluted EPS | — | 2.9 | 1.5 | 2.6 |
Basic average shares | — | 1.7B | 1.8B | 1.7B |
Diluted average shares | — | 1.7B | 1.8B | 1.7B |
EBITDA | 29.9B | 18.7B | 25.3B | 27.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.5B | 180M | -2.4B | -1.8B |
Preferred stock dividends | 0 | 0 | 0 | 0 |